Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: Results of a longitudinal, population-based study-Reference-Cited by-同舟云学术

Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: Results of a longitudinal, population-based study

Published:2010-04 Issue:4 Volume:32 Page:729-741
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Law Michael R.,Lu Christine Y.,Soumerai Stephen B.,Graves Amy Johnson,LeCates Robert F.,Zhang Fang,Ross-Degnan Dennis,Adams Alyce S.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. The pharmaceutical industry versus Medicaid—limits on state initiatives to control prescription-drug costs;Mello;N Engl J Med,2004

2. National health spending in 2005: The slowdown continues [published correction appears in Health Aff (Millwood). 2007;26:595];Catlin;Health Aff (Millwood),2007

3. State Medicaid Program Issues: Preferred Drug Lists;Owens,2003

4. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid;Soumerai;Health Aff (Millwood),2004

5. Impact of Medicaid prior authorization on angiotensin-receptor blockers: Can policy promote rational prescribing?;Fischer;Health Aff (Millwood),2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Economic Policies With Hypertension Management and Control;JAMA Health Forum;2024-02-09

2. Prescriptions of opioid-containing drugs in patients with chronic cough;Therapeutic Advances in Respiratory Disease;2024-01

3. Utilization Management in the Medicare Part D Program and Prescription Drug Utilization;Forum for Health Economics and Policy;2021-06-01

4. Cost containment by peer prior authorization program for second line treatment in patients with retinal disease;Israel Journal of Health Policy Research;2021-01-25

5. Evaluating and Improving Physician Prescribing;Pharmacoepidemiology;2019-10-18